Allianz Asset Management GmbH Trims Holdings in ICU Medical, Inc. $ICUI

Allianz Asset Management GmbH lowered its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 64.3% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 11,610 shares of the medical instruments supplier’s stock after selling 20,896 shares during the quarter. Allianz Asset Management GmbH’s holdings in ICU Medical were worth $1,393,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ICUI. AlphaQuest LLC raised its holdings in shares of ICU Medical by 189.7% during the 3rd quarter. AlphaQuest LLC now owns 4,392 shares of the medical instruments supplier’s stock worth $527,000 after acquiring an additional 2,876 shares during the period. Arizona State Retirement System increased its position in ICU Medical by 1.3% during the third quarter. Arizona State Retirement System now owns 6,903 shares of the medical instruments supplier’s stock worth $828,000 after purchasing an additional 91 shares during the last quarter. New York State Common Retirement Fund raised its stake in ICU Medical by 15.4% during the third quarter. New York State Common Retirement Fund now owns 20,693 shares of the medical instruments supplier’s stock worth $2,482,000 after purchasing an additional 2,756 shares during the period. Federated Hermes Inc. raised its stake in ICU Medical by 56.5% during the third quarter. Federated Hermes Inc. now owns 290,292 shares of the medical instruments supplier’s stock worth $34,823,000 after purchasing an additional 104,798 shares during the period. Finally, Emerald Mutual Fund Advisers Trust acquired a new position in ICU Medical in the 3rd quarter valued at about $1,096,000. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Trading Up 2.0%

Shares of ICUI stock opened at $144.90 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.19 and a current ratio of 2.45. The stock has a market capitalization of $3.58 billion, a P/E ratio of -467.40 and a beta of 0.79. The company has a 50 day moving average price of $148.95 and a 200 day moving average price of $135.09. ICU Medical, Inc. has a fifty-two week low of $107.00 and a fifty-two week high of $165.17.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on ICUI shares. Weiss Ratings restated a “sell (d-)” rating on shares of ICU Medical in a report on Thursday, January 22nd. Piper Sandler increased their price objective on ICU Medical from $153.00 to $172.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. KeyCorp raised their target price on ICU Medical from $173.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Finally, Wall Street Zen downgraded ICU Medical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $175.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.